|
USRE30985E
(en)
|
1978-01-01 |
1982-06-29 |
|
Serum-free cell culture media
|
|
US4560655A
(en)
|
1982-12-16 |
1985-12-24 |
Immunex Corporation |
Serum-free cell culture medium and process for making same
|
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4767704A
(en)
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
|
GB8516415D0
(en)
|
1985-06-28 |
1985-07-31 |
Celltech Ltd |
Culture of animal cells
|
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
|
US4927762A
(en)
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
|
ATE135397T1
(de)
|
1988-09-23 |
1996-03-15 |
Cetus Oncology Corp |
Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
EP0368684B2
(en)
|
1988-11-11 |
2004-09-29 |
Medical Research Council |
Cloning immunoglobulin variable domain sequences.
|
|
US5530101A
(en)
*
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
DE69120146T2
(de)
|
1990-01-12 |
1996-12-12 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
|
WO1996033735A1
(en)
|
1995-04-27 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
ATE158021T1
(de)
|
1990-08-29 |
1997-09-15 |
Genpharm Int |
Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
|
|
US5122469A
(en)
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
US5571894A
(en)
|
1991-02-05 |
1996-11-05 |
Ciba-Geigy Corporation |
Recombinant antibodies specific for a growth factor receptor
|
|
FI941572A7
(fi)
|
1991-10-07 |
1994-05-27 |
Oncologix Inc |
Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenete lmä
|
|
CA2372813A1
(en)
|
1992-02-06 |
1993-08-19 |
L.L. Houston |
Biosynthetic binding protein for cancer marker
|
|
CA2140280A1
(en)
|
1992-08-17 |
1994-03-03 |
Avi J. Ashkenazi |
Bispecific immunoadhesins
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
EP0914452A2
(en)
|
1996-06-17 |
1999-05-12 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Novel ptp20, pcp-2, bdp1, clk and sirp proteins and related products and methods
|
|
US6143559A
(en)
|
1996-11-18 |
2000-11-07 |
Arch Development Corporation |
Methods for the production of chicken monoclonal antibodies
|
|
CA2722378C
(en)
|
1996-12-03 |
2015-02-03 |
Amgen Fremont Inc. |
Human antibodies that bind tnf.alpha.
|
|
CA2226962A1
(en)
|
1998-02-16 |
1999-08-16 |
Marie Sarfati |
Use of binding agents to cd47 and its ligands in the treatment or the prophylaxis of various inflammatory, autoimmune and allergic diseases and in the treatment of graft rejection
|
|
EP1048299A1
(en)
|
1999-04-28 |
2000-11-02 |
Faculteit der Geneeskunde van de Vrije Universiteit |
Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
|
|
WO2001040307A1
(de)
|
1999-11-30 |
2001-06-07 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
Antikörper gegen signal-regulator-proteine
|
|
GB9930706D0
(en)
|
1999-12-24 |
2000-02-16 |
Medical Res Council |
Composition for inhibiting macrophage activity
|
|
US7083784B2
(en)
*
|
2000-12-12 |
2006-08-01 |
Medimmune, Inc. |
Molecules with extended half-lives, compositions and uses thereof
|
|
WO2002092784A2
(en)
|
2001-05-15 |
2002-11-21 |
Emory University |
POLYNUCLEOTIDES AND POLYPEPTIDES RELATING TO THE MODULATION OF SIRP α-CD47
|
|
EP1585768A2
(en)
|
2003-01-23 |
2005-10-19 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
|
WO2005014653A2
(en)
|
2003-02-28 |
2005-02-17 |
Protein Design Labs, Inc. |
Humanized chicken antibodies
|
|
US8613922B2
(en)
|
2003-04-24 |
2013-12-24 |
The University Of North Carolina At Chapel Hill |
Methods for inhibiting diabetic retinopathy with an antibody against integrin associated protein (IAP)
|
|
US20040213792A1
(en)
|
2003-04-24 |
2004-10-28 |
Clemmons David R. |
Method for inhibiting cellular activation by insulin-like growth factor-1
|
|
US20100215640A1
(en)
|
2003-04-24 |
2010-08-26 |
The University Of North Carolina At Chapel Hill |
Method for inhibiting cellular activation by insulin-like growth factor-1
|
|
TWI306862B
(en)
|
2005-01-03 |
2009-03-01 |
Hoffmann La Roche |
Antibodies against il-13 receptor alpha 1 and uses thereof
|
|
CA2625681C
(en)
|
2005-10-12 |
2016-08-02 |
Morphosys Ag |
Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38
|
|
EP2573112A1
(en)
|
2007-10-11 |
2013-03-27 |
The Hospital For Sick Children |
Modulation of sirpa - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor
|
|
ES2582340T3
(es)
|
2008-01-15 |
2016-09-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Métodos para manipular fagocitosis mediada por CD47
|
|
EP3043181B1
(en)
|
2008-01-15 |
2020-04-08 |
The Board of Trustees of the Leland Stanford Junior University |
Markers of acute myeloid leukemia stem cells
|
|
WO2009111014A2
(en)
|
2008-03-04 |
2009-09-11 |
Crystal Bioscience Inc. |
Gel microdrop composition and method of using the same
|
|
EP2111869A1
(en)
|
2008-04-23 |
2009-10-28 |
Stichting Sanquin Bloedvoorziening |
Compositions and methods to enhance the immune system
|
|
AU2010282508B2
(en)
|
2009-08-13 |
2015-05-28 |
Crystal Bioscience Inc. |
Transgenic animal for production of antibodies having minimal CDRs
|
|
WO2011041453A1
(en)
|
2009-09-29 |
2011-04-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Isolation and use of melanoma cancer stem cells
|
|
CA2809498C
(en)
|
2010-08-27 |
2020-03-31 |
University Health Network |
Methods for enriching pluripotent stem cell-derived cardiomyocyte progenitor cells and cardiomyocyte cells based on sirpa expression
|
|
US9380769B2
(en)
|
2011-05-24 |
2016-07-05 |
Crystal Bioscience Inc. |
Transgenic chicken comprising an inactivated immunoglobulin gene
|
|
WO2013056352A1
(en)
|
2011-10-19 |
2013-04-25 |
University Health Network |
Antibodies and antibody fragments targeting sirp-alpha and their use in treating hematologic cancers
|
|
US9394372B2
(en)
|
2011-10-21 |
2016-07-19 |
Crystal Bioscience Inc. |
In vivo method for generating diversity in a protein scaffold
|
|
EP3144389B1
(en)
|
2011-12-30 |
2018-05-09 |
Cellscript, Llc |
Making and using in vitro-synthesized ssrna for introducing into mammalian cells to induce a biological or biochemical effect
|
|
MX377561B
(es)
|
2012-11-05 |
2025-03-10 |
Regeneron Pharma |
Animales no humanos genéticamente modificados y métodos de uso de los mismos.
|
|
PL3575326T3
(pl)
|
2012-12-17 |
2022-07-11 |
Pf Argentum Ip Holdings Llc |
Leczenie komórek chorobowych cd47+ z użyciem fuzji sirp alfa-fc
|
|
EP2953633B1
(en)
|
2013-02-05 |
2017-10-04 |
The Board of Trustees of the Leland Stanford Junior University |
Cd47 targeted therapies for the treatment of infectious disease
|
|
CN112245586A
(zh)
|
2013-03-15 |
2021-01-22 |
小利兰·斯坦福大学托管委员会 |
用于实现治疗有效剂量的抗cd47剂的方法
|
|
JP6843611B2
(ja)
|
2013-04-29 |
2021-03-17 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
免疫を強化する抗ｃｄ４７因子の使用
|
|
EP3046627B1
(en)
|
2013-09-18 |
2019-10-23 |
The Board of Trustees of the Leland Stanford Junior University |
Modulation of efferocytosis pathways for treatment of atherosclerotic disease
|
|
CN106456748A
(zh)
|
2014-01-08 |
2017-02-22 |
小利兰·斯坦福大学托管委员会 |
小细胞肺癌的靶向疗法
|
|
CN106456749B
(zh)
*
|
2014-03-11 |
2021-03-30 |
小利兰·斯坦福大学托管委员会 |
抗SIRPα抗体和双特异性巨噬细胞增强型抗体
|
|
WO2016023040A1
(en)
|
2014-08-08 |
2016-02-11 |
Alexo Therapeutics International |
Sirp-alpha variant constructs and uses thereof
|
|
PL3180363T3
(pl)
|
2014-08-15 |
2020-02-28 |
Merck Patent Gmbh |
Białka fuzyjne immunoglobulin sirp-alfa
|
|
EP4257145B1
(en)
|
2014-08-26 |
2025-06-25 |
The Board of Trustees of the Leland Stanford Junior University |
Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
|
|
CA2959821C
(en)
|
2014-10-24 |
2024-10-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for inducing phagocytosis of MHC class I positive cells and for overcoming resistance to anti-CD47 agents/SIRPA
|
|
EP3012271A1
(en)
|
2014-10-24 |
2016-04-27 |
Effimune |
Method and compositions for inducing differentiation of myeloid derived suppressor cell to treat cancer and infectious diseases
|
|
ES2761861T3
(es)
|
2015-01-21 |
2020-05-21 |
Univ Leland Stanford Junior |
Uso de agonistas de TLR y agente anti-CD47 para mejorar la fagocitosis de las células cancerosas
|
|
WO2016205042A1
(en)
|
2015-06-16 |
2016-12-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
SIRPα AGONIST ANTIBODY
|
|
IL315940A
(en)
|
2015-07-28 |
2024-11-01 |
Univ Pennsylvania |
Altered monocytes/macrophages expressing chimeric antigen receptors and their uses
|
|
AU2016310348B2
(en)
|
2015-08-26 |
2023-01-05 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhanced depletion of targeted cells with CD47 blockade and an immune costimulatory agonist
|
|
WO2017068164A1
(en)
|
2015-10-21 |
2017-04-27 |
Ose Immunotherapeutics |
Methods and compositions for modifying macrophage polarization into pro-inflammatory cells to treat cancer
|
|
US10946042B2
(en)
|
2015-12-01 |
2021-03-16 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for selective phagocytosis of human cancer cells
|
|
CN108367073A
(zh)
|
2015-12-11 |
2018-08-03 |
小利兰·斯坦福大学托管委员会 |
以双重靶向cd47和egfr来治疗癌症
|
|
WO2017180519A1
(en)
|
2016-04-10 |
2017-10-19 |
George State University Research Foundation, Inc. |
Methods for treating cancer and inhibiting graft rejection
|
|
IL262251B2
(en)
|
2016-04-14 |
2023-09-01 |
Ose Immunotherapeutics |
New anti-syrap antibodies and their medical applications
|
|
BR112018070823A2
(pt)
*
|
2016-04-14 |
2019-02-05 |
Ose Immunotherapeutics |
anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno, composição farmacêutica, produto de combinação, molécula de ácido nucleico isolada, vetor, célula hospedeira isolada, polipeptídeo, métodos para fabricar um anticorpo, in vitro ou ex vivo para determinar células positivas para sirpa, de diagnóstico e para prever a resposta de um sujeito, e, uso de um anticorpo anti-sirpa ou um fragmento de ligação a antígeno do mesmo ou um mimético de ligação a anticorpo e in vitro ou ex vivo de pelo menos um anticorpo sirpa anti-humano ou fragmento de ligação a antígeno do mesmo ou mimético de anticorpo de ligação a antígeno.
|
|
WO2018008470A1
(ja)
|
2016-07-05 |
2018-01-11 |
国立大学法人神戸大学 |
抗腫瘍剤
|
|
CN109862910A
(zh)
|
2016-08-03 |
2019-06-07 |
小利兰·斯坦福大学托管委员会 |
破坏巨噬细胞上的Fc受体接合增强抗SIRPα抗体疗法的功效
|
|
JOP20190009A1
(ar)
|
2016-09-21 |
2019-01-27 |
Alx Oncology Inc |
أجسام مضادة ضد بروتين ألفا منظم للإشارات وطرق استخدامها
|
|
AU2017371070B2
(en)
|
2016-12-09 |
2025-01-02 |
Alector Llc |
Anti-SIRP-alpha antibodies and methods of use thereof
|
|
KR20190109440A
(ko)
|
2017-01-30 |
2019-09-25 |
더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 |
줄기 세포 이식을 위한 비-유전독성 컨디셔닝 레지멘
|
|
KR102702926B1
(ko)
|
2017-04-13 |
2024-09-06 |
사이로파 비.브이. |
항-sirp 알파 항체
|
|
CN118271443A
(zh)
|
2017-05-16 |
2024-07-02 |
拜奥迪斯私人有限公司 |
抗SIRPα抗体
|
|
BR112020001653A2
(pt)
|
2017-07-26 |
2020-07-21 |
Forty Seven, Inc. |
anticorpos anti-sirp-alfa e métodos relacionados
|
|
PE20201265A1
(es)
|
2018-03-21 |
2020-11-19 |
Alx Oncology Inc |
Anticuerpos contra proteina alfa reguladora de senal y metodos de uso
|
|
JP7337099B2
(ja)
|
2018-05-25 |
2023-09-01 |
アレクトル エルエルシー |
抗ｓｉｒｐａ抗体およびその使用法
|
|
SG11202012338QA
(en)
|
2018-07-10 |
2021-01-28 |
Univ Kobe Nat Univ Corp |
ANTI-SIRPa ANTIBODY
|
|
US11591390B2
(en)
|
2018-09-27 |
2023-02-28 |
Celgene Corporation |
SIRP-α binding proteins and methods of use thereof
|
|
JP2022507295A
(ja)
|
2018-11-14 |
2022-01-18 |
アーチ オンコロジー，インコーポレイテッド |
治療用ＳＩＲＰα抗体
|
|
JP7451520B2
(ja)
|
2018-11-15 |
2024-03-18 |
ビョンディス・ビー．ブイ． |
ヒト化抗ＳＩＲＰα抗体
|